Cancer News

News

Cancer drug reverses Alzheimer's in mice
www.newscientist.com | Feb 10, 2012
A drug approved for use in humans reverses Alzheimer's disease in mice, but may not have such dramatic effects in people with the condition

SD Life Sciences Roundup: Illumina, Applied Proteomics, & Tocagen | Xconomy
www.xconomy.com | Feb 10, 2012
---It wasn't exactly news when the board at San Diego-based Illumina (NASDAQ: ]) said it had rejected the $5.7 billion hostile takeover offer from Swiss drug

Newsvine - FDA panel votes against Xgeva for prostate cancer
www.newsvine.com | Feb 8, 2012
A panel of cancer experts has voted against a new use for Amgen's Xgeva in prostate cancer, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients

Newlywed Victoria Cornish shares how she copes with an incurable cancer - mirror.co.uk
www.mirror.co.uk | Feb 8, 2012
Walking down the aisle to marry my gorgeous boyfriend Darren, all the pain, stress and worry of the past year simply melted away.

Bahrain MOH signs agreement with SAH Global to bring Bahraini cancer patients to receive proton
www.ameinfo.com | Feb 5, 2012
The Ministry of Health of the Kingdom of Bahrain and SAH Global have signed a Memorandum of Understanding (MOU) to make cutting edge proton therapy cancer treatment available to Bahraini cancer...

Aarkstore.com Colorectal Cancer – Executive Market Summary 2011 | PRLog
www.prlog.org | Feb 3, 2012
Aarkstore.com Colorectal Cancer – Executive Market Summary 2011. Dear customer Aarkstore announce a new report "Colorectal Cancer – Executive Market Summary 2011 " through its vast collection of market research report - PR11789343

The Compliance Resource Center » Radon the Silent Killer
www.thecrcenter.com | Feb 2, 2012
Test Your Home For Radon. Radon is the leading cause of non-smoking lung cancer. The only way to know if you and your family are at risk from radon is to test your home. The U.S. Surgeon General and EPA recommend that all homes be tested.

Abiraterone prostate cancer treatment to be covered by Axa PPP | Money | The Guardian
www.guardian.co.uk | Feb 2, 2012
Change of stance on abiraterone by UK's second largest private medical insurance firm brings it into line with Bupa and WPA

FitchResearch
www.fitchratings.com | Jan 27, 2012
Fitch Ratings About Us Contact Us Press Room Events Help Search Sign in Autologin Printer-Friendly Page Click Here for Printer-Friendly Version Fitch Rates Memorial Sloan-Kettering Cancer Center's (NY) Series 2012 Revs 'AA'; Outlook Stable Ratings Endorsement Policy 27 Jan 2012 2:16 PM (EST) Fitch

BTG revenues grow on US drug approval - FT.com
www.ft.com | Jan 25, 2012
BTG, the specialist pharmaceuticals group, confirmed on Wednesday that full-year revenues would rise by about 40 per cent in the wake US regulators’ approval last week of a drug to treat blood toxicity in cancer patients. The FTSE 250 company said